Kangstem Biotech Co., Ltd.

KOSDAQ:A217730 株式レポート

時価総額：₩181.2b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Kangstem Biotech マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Jong-Cheon Na

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権n/a
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Is Kangstem Biotech (KOSDAQ:217730) Using Debt Sensibly?

May 24
Is Kangstem Biotech (KOSDAQ:217730) Using Debt Sensibly?

Investors Don't See Light At End Of Kangstem Biotech Co., Ltd.'s (KOSDAQ:217730) Tunnel

Mar 06
Investors Don't See Light At End Of Kangstem Biotech Co., Ltd.'s (KOSDAQ:217730) Tunnel

Is Kangstem Biotech (KOSDAQ:217730) Weighed On By Its Debt Load?

Feb 17
Is Kangstem Biotech (KOSDAQ:217730) Weighed On By Its Debt Load?

Would Shareholders Who Purchased Kang Stem Biotech's (KOSDAQ:217730) Stock Three Years Be Happy With The Share price Today?

Dec 26
Would Shareholders Who Purchased Kang Stem Biotech's (KOSDAQ:217730) Stock Three Years Be Happy With The Share price Today?

CEO（最高経営責任者

Jong-Cheon Na

no data

在職期間

Jong-Cheon Na serves as Chief Executive Officer of Kangstem Biotech Co., Ltd.